Amanda Law
Concepts (323)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Schizophrenia | 32 | 2019 | 418 | 7.220 |
Why?
| Neuregulin-1 | 17 | 2020 | 41 | 3.690 |
Why?
| Prefrontal Cortex | 13 | 2020 | 267 | 2.960 |
Why?
| Neuregulins | 5 | 2020 | 7 | 2.590 |
Why?
| Hippocampus | 16 | 2020 | 709 | 2.020 |
Why?
| ErbB Receptors | 8 | 2020 | 557 | 1.880 |
Why?
| Nerve Tissue Proteins | 10 | 2015 | 535 | 1.750 |
Why?
| Alternative Splicing | 6 | 2020 | 187 | 1.600 |
Why?
| Brain | 15 | 2021 | 2370 | 1.600 |
Why?
| Proto-Oncogene Proteins c-akt | 5 | 2020 | 400 | 1.450 |
Why?
| Choline | 9 | 2022 | 108 | 1.320 |
Why?
| TOR Serine-Threonine Kinases | 3 | 2020 | 362 | 1.220 |
Why?
| Bipolar Disorder | 4 | 2016 | 208 | 1.120 |
Why?
| Behavior, Animal | 4 | 2020 | 472 | 1.100 |
Why?
| Prenatal Exposure Delayed Effects | 7 | 2021 | 447 | 1.090 |
Why?
| Protein Isoforms | 10 | 2018 | 339 | 1.080 |
Why?
| Gene Expression Regulation, Developmental | 7 | 2020 | 794 | 1.030 |
Why?
| Cell Adhesion Molecules, Neuronal | 3 | 2015 | 35 | 0.980 |
Why?
| Genetic Predisposition to Disease | 10 | 2019 | 2125 | 0.970 |
Why?
| Antipsychotic Agents | 6 | 2016 | 183 | 0.910 |
Why?
| Gene Expression | 9 | 2018 | 1435 | 0.900 |
Why?
| MicroRNAs | 2 | 2019 | 607 | 0.870 |
Why?
| Phosphatidylinositol 3-Kinases | 3 | 2020 | 332 | 0.850 |
Why?
| Receptor, ErbB-4 | 9 | 2020 | 19 | 0.840 |
Why?
| Fetus | 8 | 2021 | 702 | 0.780 |
Why?
| Class I Phosphatidylinositol 3-Kinases | 2 | 2019 | 76 | 0.770 |
Why?
| Polymorphism, Single Nucleotide | 9 | 2014 | 1918 | 0.760 |
Why?
| Aging | 4 | 2020 | 1631 | 0.750 |
Why?
| Brain Chemistry | 4 | 2009 | 116 | 0.740 |
Why?
| Maternal Deprivation | 3 | 2010 | 15 | 0.730 |
Why?
| RNA, Messenger | 15 | 2020 | 2574 | 0.720 |
Why?
| Fetal Development | 7 | 2021 | 247 | 0.720 |
Why?
| C-Reactive Protein | 4 | 2022 | 364 | 0.710 |
Why?
| Sensory Gating | 2 | 2019 | 38 | 0.690 |
Why?
| Minisatellite Repeats | 1 | 2019 | 39 | 0.670 |
Why?
| Signal Transduction | 9 | 2018 | 4541 | 0.670 |
Why?
| Depressive Disorder, Major | 3 | 2016 | 304 | 0.630 |
Why?
| Genotype | 8 | 2016 | 1786 | 0.620 |
Why?
| Cloning, Molecular | 2 | 2010 | 523 | 0.600 |
Why?
| gamma-Aminobutyric Acid | 3 | 2018 | 151 | 0.590 |
Why?
| Gene Expression Regulation | 5 | 2019 | 2353 | 0.590 |
Why?
| Interleukin-1beta | 1 | 2019 | 370 | 0.580 |
Why?
| Cerebral Cortex | 3 | 2011 | 386 | 0.570 |
Why?
| Glutamic Acid | 1 | 2018 | 213 | 0.550 |
Why?
| Neurophysiology | 1 | 2016 | 14 | 0.540 |
Why?
| Memory Disorders | 1 | 2017 | 155 | 0.530 |
Why?
| Multiprotein Complexes | 1 | 2017 | 145 | 0.530 |
Why?
| Microfilament Proteins | 3 | 2008 | 126 | 0.520 |
Why?
| Mood Disorders | 2 | 2008 | 117 | 0.520 |
Why?
| Microtubule-Associated Proteins | 3 | 2008 | 174 | 0.510 |
Why?
| Neocortex | 1 | 2015 | 25 | 0.500 |
Why?
| Adult | 29 | 2022 | 30718 | 0.500 |
Why?
| Psychomotor Performance | 2 | 2014 | 278 | 0.480 |
Why?
| Gestational Age | 5 | 2022 | 757 | 0.480 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2019 | 1137 | 0.470 |
Why?
| Epidermal Growth Factor | 1 | 2014 | 161 | 0.460 |
Why?
| Neurogenesis | 1 | 2014 | 102 | 0.440 |
Why?
| Female | 36 | 2022 | 59913 | 0.410 |
Why?
| Alleles | 3 | 2011 | 794 | 0.410 |
Why?
| Pregnancy Complications, Infectious | 3 | 2021 | 289 | 0.410 |
Why?
| Promoter Regions, Genetic | 4 | 2019 | 1122 | 0.400 |
Why?
| Receptors, N-Methyl-D-Aspartate | 2 | 2003 | 182 | 0.400 |
Why?
| Pregnancy | 14 | 2022 | 5548 | 0.390 |
Why?
| Humans | 50 | 2024 | 115587 | 0.390 |
Why?
| Male | 31 | 2022 | 55949 | 0.390 |
Why?
| Inflammation | 3 | 2021 | 2499 | 0.380 |
Why?
| Infant, Newborn | 12 | 2022 | 5077 | 0.370 |
Why?
| Heterozygote | 1 | 2011 | 252 | 0.370 |
Why?
| Quinazolines | 1 | 2012 | 241 | 0.360 |
Why?
| Adenine | 1 | 2012 | 221 | 0.360 |
Why?
| Infant Behavior | 2 | 2020 | 23 | 0.350 |
Why?
| Phenotype | 2 | 2014 | 2829 | 0.340 |
Why?
| Pyramidal Cells | 3 | 2004 | 51 | 0.340 |
Why?
| Peptides | 1 | 2014 | 864 | 0.330 |
Why?
| Paternal Deprivation | 1 | 2008 | 2 | 0.320 |
Why?
| Young Adult | 11 | 2022 | 10470 | 0.320 |
Why?
| Gyrus Cinguli | 1 | 2008 | 69 | 0.320 |
Why?
| Animals | 17 | 2021 | 32102 | 0.320 |
Why?
| Middle Aged | 17 | 2019 | 26999 | 0.310 |
Why?
| Genome-Wide Association Study | 5 | 2019 | 1217 | 0.310 |
Why?
| Case-Control Studies | 7 | 2019 | 3022 | 0.310 |
Why?
| Disease Models, Animal | 3 | 2016 | 3580 | 0.300 |
Why?
| Mice | 8 | 2020 | 15052 | 0.290 |
Why?
| Amygdala | 1 | 2008 | 179 | 0.290 |
Why?
| Memory, Short-Term | 3 | 2018 | 224 | 0.290 |
Why?
| Cyclophilins | 2 | 2004 | 29 | 0.280 |
Why?
| Neuronal Plasticity | 2 | 2008 | 214 | 0.280 |
Why?
| Infant | 10 | 2021 | 7979 | 0.280 |
Why?
| Blotting, Western | 3 | 2016 | 1153 | 0.270 |
Why?
| Psychotic Disorders | 2 | 2021 | 123 | 0.270 |
Why?
| Pregnancy Complications | 2 | 2021 | 430 | 0.270 |
Why?
| Neurobiology | 1 | 2006 | 17 | 0.260 |
Why?
| Cohort Studies | 8 | 2016 | 4944 | 0.250 |
Why?
| Adolescent | 11 | 2019 | 17889 | 0.250 |
Why?
| Neural Cell Adhesion Molecules | 2 | 2015 | 23 | 0.250 |
Why?
| Protein Structure, Tertiary | 1 | 2006 | 804 | 0.230 |
Why?
| Pneumocephalus | 1 | 2024 | 2 | 0.230 |
Why?
| Neurites | 1 | 2004 | 43 | 0.230 |
Why?
| Dendrites | 1 | 2004 | 85 | 0.230 |
Why?
| Hydrocortisone | 2 | 2020 | 273 | 0.230 |
Why?
| Memory | 2 | 2016 | 211 | 0.220 |
Why?
| Antibodies, Anti-Idiotypic | 1 | 2003 | 54 | 0.220 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 930 | 0.220 |
Why?
| Neurofilament Proteins | 1 | 2003 | 34 | 0.220 |
Why?
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 317 | 0.220 |
Why?
| Aged | 10 | 2019 | 19251 | 0.220 |
Why?
| Calcium-Binding Proteins | 2 | 2015 | 203 | 0.220 |
Why?
| Folic Acid | 2 | 2021 | 159 | 0.220 |
Why?
| Synapses | 3 | 2004 | 336 | 0.210 |
Why?
| Infant, Small for Gestational Age | 1 | 2022 | 75 | 0.200 |
Why?
| Child Development | 3 | 2021 | 389 | 0.200 |
Why?
| Child, Preschool | 9 | 2021 | 9133 | 0.200 |
Why?
| Heart Rate, Fetal | 1 | 2021 | 21 | 0.200 |
Why?
| Risk Factors | 7 | 2021 | 8697 | 0.190 |
Why?
| Child | 11 | 2021 | 18488 | 0.190 |
Why?
| Risk | 2 | 2014 | 819 | 0.190 |
Why?
| In Situ Hybridization | 4 | 2010 | 298 | 0.190 |
Why?
| Up-Regulation | 3 | 2019 | 820 | 0.190 |
Why?
| Mothers | 3 | 2021 | 666 | 0.180 |
Why?
| Callithrix | 3 | 2010 | 8 | 0.180 |
Why?
| Molecular Sequence Data | 3 | 2010 | 2790 | 0.180 |
Why?
| Receptor, ErbB-3 | 1 | 2020 | 42 | 0.180 |
Why?
| Aged, 80 and over | 4 | 2016 | 6417 | 0.180 |
Why?
| Nerve Growth Factors | 1 | 2020 | 73 | 0.170 |
Why?
| Animals, Newborn | 2 | 2014 | 780 | 0.170 |
Why?
| HEK293 Cells | 2 | 2019 | 602 | 0.170 |
Why?
| 5' Untranslated Regions | 1 | 2019 | 51 | 0.170 |
Why?
| Hallucinogens | 1 | 2021 | 73 | 0.170 |
Why?
| Neurons | 3 | 2019 | 1298 | 0.170 |
Why?
| Organ Specificity | 1 | 2019 | 273 | 0.160 |
Why?
| Haplotypes | 4 | 2013 | 457 | 0.160 |
Why?
| Nutritional Status | 1 | 2021 | 289 | 0.160 |
Why?
| Analysis of Variance | 3 | 2012 | 1227 | 0.160 |
Why?
| Mice, Transgenic | 4 | 2018 | 1970 | 0.150 |
Why?
| Adrenal Cortex Hormones | 1 | 2021 | 509 | 0.150 |
Why?
| Receptor, ErbB-2 | 1 | 2020 | 302 | 0.150 |
Why?
| Exons | 2 | 2010 | 300 | 0.150 |
Why?
| Premature Birth | 1 | 2021 | 278 | 0.150 |
Why?
| Age of Onset | 1 | 2019 | 450 | 0.150 |
Why?
| RNA, Long Noncoding | 1 | 2020 | 157 | 0.150 |
Why?
| Psychiatric Status Rating Scales | 3 | 2014 | 485 | 0.150 |
Why?
| Cell Lineage | 1 | 2019 | 310 | 0.150 |
Why?
| Maternal Exposure | 1 | 2019 | 138 | 0.150 |
Why?
| alpha7 Nicotinic Acetylcholine Receptor | 2 | 2015 | 96 | 0.140 |
Why?
| Placenta | 2 | 2021 | 624 | 0.140 |
Why?
| Solute Carrier Family 12, Member 2 | 2 | 2014 | 7 | 0.140 |
Why?
| Betacoronavirus | 1 | 2020 | 254 | 0.140 |
Why?
| Autopsy | 2 | 2014 | 86 | 0.140 |
Why?
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2017 | 57 | 0.140 |
Why?
| Genetic Markers | 2 | 2010 | 325 | 0.140 |
Why?
| Conditioning, Classical | 1 | 2017 | 87 | 0.140 |
Why?
| Reflex, Startle | 2 | 2014 | 58 | 0.140 |
Why?
| Locomotion | 1 | 2017 | 81 | 0.140 |
Why?
| Depression | 2 | 2021 | 1145 | 0.130 |
Why?
| Oxygen | 3 | 2024 | 837 | 0.130 |
Why?
| Rats, Sprague-Dawley | 3 | 2012 | 2262 | 0.130 |
Why?
| Immunohistochemistry | 3 | 2004 | 1642 | 0.120 |
Why?
| Phosphatidylcholines | 1 | 2015 | 134 | 0.120 |
Why?
| Tissue Distribution | 2 | 2006 | 324 | 0.120 |
Why?
| Cannabis | 1 | 2021 | 381 | 0.120 |
Why?
| Fear | 1 | 2017 | 297 | 0.120 |
Why?
| Genotyping Techniques | 1 | 2014 | 70 | 0.120 |
Why?
| DiGeorge Syndrome | 1 | 2013 | 19 | 0.110 |
Why?
| Blood-Brain Barrier | 1 | 2014 | 106 | 0.110 |
Why?
| Child Behavior | 1 | 2015 | 218 | 0.110 |
Why?
| Catechol O-Methyltransferase | 1 | 2013 | 16 | 0.110 |
Why?
| Transcription, Genetic | 1 | 2019 | 1310 | 0.110 |
Why?
| Polymorphism, Genetic | 1 | 2016 | 621 | 0.110 |
Why?
| Mental Disorders | 1 | 2021 | 902 | 0.110 |
Why?
| Double-Blind Method | 2 | 2015 | 1660 | 0.110 |
Why?
| Photic Stimulation | 1 | 2014 | 203 | 0.110 |
Why?
| Dietary Supplements | 3 | 2021 | 458 | 0.110 |
Why?
| Pharmacogenetics | 1 | 2014 | 151 | 0.110 |
Why?
| Amphetamine | 1 | 2012 | 22 | 0.100 |
Why?
| Rats | 3 | 2012 | 5034 | 0.100 |
Why?
| Cross-Over Studies | 1 | 2014 | 434 | 0.100 |
Why?
| Cell Line, Transformed | 1 | 2012 | 133 | 0.100 |
Why?
| Mice, Inbred C57BL | 3 | 2018 | 4773 | 0.100 |
Why?
| Cerebellum | 2 | 2004 | 200 | 0.100 |
Why?
| Biological Clocks | 1 | 2011 | 39 | 0.100 |
Why?
| Neuropsychiatry | 1 | 2011 | 15 | 0.090 |
Why?
| Synaptophysin | 2 | 2008 | 11 | 0.090 |
Why?
| Molecular Structure | 1 | 2012 | 447 | 0.090 |
Why?
| Drug Discovery | 1 | 2011 | 124 | 0.090 |
Why?
| Genetic Association Studies | 1 | 2012 | 343 | 0.090 |
Why?
| Epistasis, Genetic | 1 | 2010 | 69 | 0.090 |
Why?
| Receptors, Mineralocorticoid | 1 | 2010 | 12 | 0.090 |
Why?
| Dose-Response Relationship, Drug | 1 | 2014 | 1870 | 0.090 |
Why?
| Family | 1 | 2014 | 594 | 0.090 |
Why?
| Long-Term Potentiation | 1 | 2011 | 145 | 0.090 |
Why?
| Adenosine | 1 | 2011 | 203 | 0.090 |
Why?
| Social Isolation | 1 | 2010 | 54 | 0.090 |
Why?
| Motor Activity | 1 | 2014 | 633 | 0.080 |
Why?
| Family Health | 1 | 2010 | 195 | 0.080 |
Why?
| Schizophrenic Psychology | 1 | 2009 | 86 | 0.080 |
Why?
| Gene Frequency | 1 | 2010 | 485 | 0.080 |
Why?
| Tritium | 1 | 2008 | 69 | 0.080 |
Why?
| Receptors, Serotonin | 1 | 2008 | 32 | 0.080 |
Why?
| Vesicular Inhibitory Amino Acid Transport Proteins | 1 | 2008 | 3 | 0.080 |
Why?
| Vesicular Glutamate Transport Protein 1 | 1 | 2008 | 3 | 0.080 |
Why?
| GAP-43 Protein | 1 | 2008 | 5 | 0.080 |
Why?
| Flow Cytometry | 1 | 2012 | 1083 | 0.080 |
Why?
| Receptors, Glucocorticoid | 1 | 2010 | 144 | 0.080 |
Why?
| Action Potentials | 1 | 2011 | 410 | 0.080 |
Why?
| Receptor, Serotonin, 5-HT1A | 1 | 2008 | 39 | 0.080 |
Why?
| Prenatal Care | 2 | 2021 | 257 | 0.080 |
Why?
| Genetic Variation | 3 | 2011 | 877 | 0.080 |
Why?
| Phosphorylation | 1 | 2012 | 1571 | 0.080 |
Why?
| Vitamin D | 2 | 2021 | 341 | 0.080 |
Why?
| Brain-Derived Neurotrophic Factor | 1 | 2008 | 106 | 0.070 |
Why?
| Gene Components | 1 | 2006 | 5 | 0.070 |
Why?
| B-Lymphocytes | 1 | 2012 | 773 | 0.070 |
Why?
| Base Sequence | 1 | 2010 | 2114 | 0.070 |
Why?
| Amino Acid Sequence | 1 | 2010 | 2000 | 0.070 |
Why?
| Piperazines | 1 | 2008 | 314 | 0.070 |
Why?
| Logistic Models | 3 | 2022 | 1856 | 0.070 |
Why?
| Synaptic Transmission | 1 | 2008 | 232 | 0.070 |
Why?
| Membrane Proteins | 2 | 2010 | 1024 | 0.070 |
Why?
| Image Processing, Computer-Assisted | 1 | 2010 | 691 | 0.070 |
Why?
| Reward | 1 | 2008 | 208 | 0.070 |
Why?
| Pyridines | 1 | 2008 | 425 | 0.060 |
Why?
| Receptors, Nicotinic | 1 | 2007 | 273 | 0.060 |
Why?
| Autoradiography | 1 | 2004 | 71 | 0.060 |
Why?
| Histocytochemistry | 1 | 2004 | 78 | 0.060 |
Why?
| Chlorpromazine | 1 | 2004 | 5 | 0.060 |
Why?
| Clozapine | 1 | 2004 | 19 | 0.060 |
Why?
| Risperidone | 1 | 2004 | 26 | 0.060 |
Why?
| Haloperidol | 1 | 2004 | 35 | 0.060 |
Why?
| Amino Acid Transport System X-AG | 1 | 2003 | 3 | 0.060 |
Why?
| Nerve Fibers, Myelinated | 1 | 2004 | 41 | 0.060 |
Why?
| Receptors, Glutamate | 1 | 2003 | 19 | 0.060 |
Why?
| Oligonucleotide Probes | 1 | 2003 | 54 | 0.060 |
Why?
| Receptors, Growth Factor | 1 | 2003 | 49 | 0.060 |
Why?
| Presynaptic Terminals | 1 | 2004 | 55 | 0.060 |
Why?
| Benzodiazepines | 1 | 2004 | 115 | 0.060 |
Why?
| Semaphorin-3A | 1 | 2003 | 2 | 0.050 |
Why?
| Protein Binding | 1 | 2008 | 1917 | 0.050 |
Why?
| Purkinje Cells | 1 | 2004 | 66 | 0.050 |
Why?
| Brain Stem | 1 | 2004 | 102 | 0.050 |
Why?
| Cell Count | 1 | 2003 | 305 | 0.050 |
Why?
| Postmortem Changes | 2 | 2014 | 16 | 0.050 |
Why?
| Binding Sites | 1 | 2006 | 1177 | 0.050 |
Why?
| Headache | 1 | 2024 | 131 | 0.050 |
Why?
| Fluorescent Antibody Technique | 1 | 2003 | 398 | 0.050 |
Why?
| Absorptiometry, Photon | 1 | 2003 | 221 | 0.050 |
Why?
| Pandemics | 2 | 2021 | 1334 | 0.050 |
Why?
| Pregnancy Trimester, Third | 1 | 2021 | 77 | 0.050 |
Why?
| Wechsler Scales | 1 | 2021 | 52 | 0.050 |
Why?
| Social Problems | 1 | 2021 | 11 | 0.050 |
Why?
| Vitamin A | 1 | 2021 | 52 | 0.050 |
Why?
| Nutritional Requirements | 1 | 2021 | 71 | 0.050 |
Why?
| Nerve Net | 1 | 2003 | 228 | 0.050 |
Why?
| Feasibility Studies | 1 | 2003 | 741 | 0.050 |
Why?
| Intelligence | 1 | 2021 | 132 | 0.050 |
Why?
| Micronutrients | 1 | 2021 | 77 | 0.040 |
Why?
| Nootropic Agents | 1 | 2020 | 26 | 0.040 |
Why?
| Treatment Outcome | 1 | 2014 | 9159 | 0.040 |
Why?
| Object Attachment | 1 | 2020 | 33 | 0.040 |
Why?
| Fatty Acids, Omega-3 | 1 | 2021 | 124 | 0.040 |
Why?
| Vitamins | 1 | 2021 | 151 | 0.040 |
Why?
| Magnetic Resonance Imaging | 1 | 2010 | 3069 | 0.040 |
Why?
| Pituitary-Adrenal System | 1 | 2020 | 162 | 0.040 |
Why?
| Hypothalamo-Hypophyseal System | 1 | 2020 | 197 | 0.040 |
Why?
| Maternal Age | 1 | 2019 | 117 | 0.040 |
Why?
| Reference Values | 2 | 2010 | 744 | 0.040 |
Why?
| Developmental Disabilities | 1 | 2021 | 240 | 0.040 |
Why?
| Transcription Factors | 1 | 2006 | 1528 | 0.040 |
Why?
| Stress, Psychological | 2 | 2020 | 974 | 0.040 |
Why?
| Urinary Tract Infections | 1 | 2019 | 136 | 0.040 |
Why?
| Antibodies, Monoclonal | 1 | 2003 | 1265 | 0.040 |
Why?
| Attention | 1 | 2020 | 394 | 0.040 |
Why?
| Encephalitis | 1 | 2018 | 127 | 0.040 |
Why?
| Respiratory Tract Infections | 1 | 2019 | 323 | 0.030 |
Why?
| Pneumonia, Viral | 1 | 2020 | 344 | 0.030 |
Why?
| Coronavirus Infections | 1 | 2020 | 336 | 0.030 |
Why?
| DNA, Recombinant | 1 | 2014 | 42 | 0.030 |
Why?
| Chromosome Deletion | 1 | 2013 | 95 | 0.030 |
Why?
| Valine | 1 | 2013 | 74 | 0.030 |
Why?
| Transcriptome | 1 | 2018 | 736 | 0.030 |
Why?
| Methionine | 1 | 2013 | 145 | 0.030 |
Why?
| Chi-Square Distribution | 1 | 2013 | 499 | 0.030 |
Why?
| Sodium-Potassium-Chloride Symporters | 1 | 2011 | 9 | 0.020 |
Why?
| New York | 1 | 2011 | 109 | 0.020 |
Why?
| Symporters | 1 | 2011 | 52 | 0.020 |
Why?
| Epigenomics | 1 | 2011 | 105 | 0.020 |
Why?
| Genetic Carrier Screening | 1 | 2010 | 24 | 0.020 |
Why?
| Glutamate Decarboxylase | 1 | 2011 | 162 | 0.020 |
Why?
| Disks Large Homolog 4 Protein | 1 | 2010 | 16 | 0.020 |
Why?
| Nitric Oxide Synthase Type I | 1 | 2010 | 26 | 0.020 |
Why?
| Cognition Disorders | 1 | 2014 | 475 | 0.020 |
Why?
| Time | 1 | 2010 | 72 | 0.020 |
Why?
| Tremor | 1 | 2009 | 45 | 0.020 |
Why?
| Movement Disorders | 1 | 2009 | 46 | 0.020 |
Why?
| Artificial Intelligence | 1 | 2010 | 148 | 0.020 |
Why?
| Molecular Targeted Therapy | 1 | 2011 | 348 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2019 | 4435 | 0.020 |
Why?
| Neural Inhibition | 1 | 2009 | 152 | 0.020 |
Why?
| Siblings | 1 | 2009 | 223 | 0.020 |
Why?
| Control Groups | 1 | 2008 | 10 | 0.020 |
Why?
| Research | 1 | 2011 | 396 | 0.020 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 388 | 0.020 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 374 | 0.020 |
Why?
| Immunoblotting | 1 | 2008 | 281 | 0.020 |
Why?
| Cytoplasm | 1 | 2008 | 255 | 0.020 |
Why?
| Pedigree | 1 | 2008 | 467 | 0.020 |
Why?
| Anxiety Disorders | 1 | 2009 | 310 | 0.020 |
Why?
| Research Design | 1 | 2011 | 946 | 0.020 |
Why?
| In Vitro Techniques | 1 | 2007 | 1044 | 0.020 |
Why?
| Down-Regulation | 1 | 2007 | 601 | 0.020 |
Why?
| Cell Nucleus | 1 | 2008 | 553 | 0.020 |
Why?
| Models, Biological | 1 | 2011 | 1646 | 0.010 |
Why?
| Cells, Cultured | 1 | 2011 | 3914 | 0.010 |
Why?
| Glutamates | 1 | 2003 | 59 | 0.010 |
Why?
| Mutation | 1 | 2014 | 3364 | 0.010 |
Why?
| Algorithms | 1 | 2010 | 1490 | 0.010 |
Why?
| Functional Laterality | 1 | 2003 | 201 | 0.010 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2003 | 45 | 0.010 |
Why?
| Serine Endopeptidases | 1 | 2003 | 102 | 0.010 |
Why?
| Extracellular Matrix Proteins | 1 | 2003 | 127 | 0.010 |
Why?
| Axons | 1 | 2003 | 179 | 0.010 |
Why?
| Smoking | 1 | 2007 | 1457 | 0.010 |
Why?
| Disease Progression | 1 | 2003 | 2418 | 0.010 |
Why?
| Biomarkers | 1 | 2003 | 3466 | 0.010 |
Why?
|
|
Law's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|